
Major provider of medical-surgical products and integrated solutions

Medline is a major provider of medical-surgical products and integrated healthcare supply chain solutions, offering over 335,000 products for all types of healthcare facilities and supported by extensive manufacturing and logistics infrastructure. The Medline IPO, representing a highly experienced and large U.S. medtech player, falls into the category of blockbuster offerings and is the largest since 2011. It is particularly attractive to a broad range of investors due to its relatively low risk profile compared to most healthcare IPOs (especially biotech companies, which have been frequent issuers in recent years), while still offering a reasonably balanced valuation range. The company generates over $25 billion in annual revenue and employs approximately 43,000 people (comparable to Boston Scientific or about half the size of Medtronic’s workforce).
Risk Warning: Investing in financial instruments involves risks. The value of investments may increase or decrease. Past results do not guarantee future returns. We recommend consulting a financial advisor before making investment decisions.
Open the direction card in Telegram for full information and application
Extended cards, materials, applications, status updates, and direct manager contact — in our Telegram Mini App
Open Telegram Mini App